Home
>
National Drug Code (NDC)
>
Carticel
Carticel - 58468-1025-1 - (autologous cultured chondrocytes)
Drug Information of Carticel
| Product NDC: | 58468-1025 |
| Proprietary Name: | Carticel |
| Non Proprietary Name: | autologous cultured chondrocytes |
| Active Ingredient(s): | 12000000 1/1 & nbsp; autologous cultured chondrocytes |
| Administration Route(s): | INTRA-ARTICULAR |
| Dosage Form(s): | IMPLANT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Carticel
| Product NDC: | 58468-1025 |
| Labeler Name: | Genzyme Corporation |
| Product Type: | CELLULAR THERAPY |
| FDA Application Number: | BLA103661 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19970822 |
Package Information of Carticel
| Package NDC: | 58468-1025-1 |
| Package Description: | 1 IMPLANT in 1 VIAL, GLASS (58468-1025-1) |
NDC Information of Carticel
| NDC Code | 58468-1025-1 |
| Proprietary Name | Carticel |
| Package Description | 1 IMPLANT in 1 VIAL, GLASS (58468-1025-1) |
| Product NDC | 58468-1025 |
| Product Type Name | CELLULAR THERAPY |
| Non Proprietary Name | autologous cultured chondrocytes |
| Dosage Form Name | IMPLANT |
| Route Name | INTRA-ARTICULAR |
| Start Marketing Date | 19970822 |
| Marketing Category Name | BLA |
| Labeler Name | Genzyme Corporation |
| Substance Name | AUTOLOGOUS CULTURED CHONDROCYTES |
| Strength Number | 12000000 |
| Strength Unit | 1/1 |
| Pharmaceutical Classes | Autologous Cultured Cell [EPC],Cells, Cultured, Autologous [Chemical/Ingredient],Chondrocytes [Chemical/Ingredient] |
